[1]
I. Jonušaitė, N. Giedraitienė, G. Kaubrys, and R. Kizlaitienė, “The Role of the New Anti-CD20 Monoclonal Antibodies in Active Relapsing – Remitting Multiple Sclerosis Treatment: Efficacy and Safety of ofatumumab”, NS, vol. 27, no. Nr. 3 (97), pp. 127–135, Mar. 2024, doi: 10.29014/NS.2023.27.97.1.